Balaxi Pharma reports 23 per cent growth YoY during Q2FY23
Pharma revenue up 50 per cent with expanding contribution from Latin America
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Balaxi Pharma
Balaxi Pharma revenue grows 42 per cent in Q1 FY23
Profit After Tax (PAT) up 32 per cent YoY